Treating breast cancer with organoid drug testing
Part of Cancer, Skin clinical trials.
This trial uses a lab-grown miniature tumor (called an organoid) from your biopsy to test which drugs might work best for your breast cancer when standard treatments have stopped working. The goal is to find a personalized treatment option that could be more effective for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 75 years old.
- You have breast cancer confirmed by a tissue sample (biopsy).
- Your cancer has either returned or gotten worse during or soon after initial treatment (within 2 years), or you have tried two different treatments that stopped working within the last 6 months.
- You are able to have a biopsy to get a fresh tissue sample for growing an organoid in the lab.
- Your doctor expects you to live at least 3 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a lab-grown mini-tumor (organoid) from your biopsy to test which chemotherapy drugs work best for your cancer before you have surgery. The goal is to personalize your treatment and improve outcomes.
This trial tests whether using a miniature version of your tumor grown in a lab can help choose the best treatment for advanced breast cancer. It compares this personalized approach to standard care.
This trial tests whether using a personalized approach—growing your tumor cells in the lab to find the best treatment—can work better than standard treatments chosen by your doctor. It is for people with advanced breast cancer that has stopped responding to at least two previous treatments.
This study is testing a new way to understand your breast cancer by growing tiny tumor samples (called organoids) in the lab. It will help researchers learn more about your cancer type and could lead to better treatments.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This study collects tumor tissue from breast cancer patients before they start chemotherapy to grow miniature versions of their tumors (organoids) in the lab. The goal is to understand how each tumor responds to treatment, which may help personalize future therapies.
Hear when a new Refractory Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.